“BPC-157 + TB-500 (10 mg/10 mg) Wolverine Blend” is a research peptide combination that pairs two well-studied experimental peptides—BPC-157 and TB-500—each at 10 mg per vial. It’s often marketed under names like Wolverine Blend because of its association in research and peptide communities with enhanced tissue repair and regeneration processes.

Here’s a breakdown of what it is and what it’s studied for:

 What the Blend Contains

• BPC-157 (Body Protection Compound-157) — a 15-amino-acid synthetic peptide derived from a protein found in human gastric juice. It’s widely used in preclinical research for its potential roles in supporting angiogenesis (formation of new blood vessels), modulating inflammation, and promoting connective tissue regeneration in models of muscle, tendon, ligament, and gut injury.

• TB-500 (Thymosin Beta-4 fragment) — a fragment of the natural peptide Thymosin β4 that maintains activity in regulating actin, cell migration, and tissue remodeling. In laboratory settings, it’s examined for its ability to promote angiogenesis and help cells move to sites where repair is needed.

 Why They’re Combined

The idea behind the Wolverine Blend is that the two peptides act on complementary pathways involved in repair and regeneration:

• BPC-157 tends to support vascular growth, inflammatory signaling modulation, and targeted connective-tissue healing.

• TB-500 enhances cellular migration, cytoskeletal remodeling, and broader tissue regeneration processes.

Together, this blend is used in controlled research environments to investigate whether synergistic effects arise from targeting multiple aspects of tissue repair at once.